These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. Bergstein JM; Riley M; Bang NU N Engl J Med; 1992 Sep; 327(11):755-9. PubMed ID: 1501651 [TBL] [Abstract][Full Text] [Related]
19. [Microalbuminuria in pediatric patients diagnosed with hemolytic uremic syndrome]. Cubillos C MP; Del Salas P; Zambrano PO Rev Chil Pediatr; 2015; 86(2):92-6. PubMed ID: 26235688 [TBL] [Abstract][Full Text] [Related]
20. Keeping the heart in mind when managing hemolytic: uremic syndrome. Machol K; Vivante A; Rubinsthein M; Dekel B; Danieli J; Paret G Isr Med Assoc J; 2011 Jul; 13(7):446-7. PubMed ID: 21838193 [No Abstract] [Full Text] [Related] [Next] [New Search]